Curanex Pharmaceuticals engages Strategic Investor Relations for investor education and visibility.

Curanex Pharmaceuticals Inc. has partnered with Strategic Investor Relations to enhance its visibility and communication with investors. The company aims to educate current and potential investors about its innovative pipeline and strategic initiatives. Curanex's botanical drug development approach focuses on high-efficacy drugs with de-risked clinical pathways and positions it in the rapidly expanding botanical drug market.